Empirical Study on Lifestyle Intervention for Elderly Hypertensive Patients in Community Based on TTM Theory

Status

Not yet recruiting

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT07492290

Enrollment

106

Registered

2026-03-25

Start date

2026-04-01

Completion date

2026-12-30

Last updated

2026-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Age More 60yr, Hypertension (HTN)

Brief summary

This study intervention is based on TTM theory and implements lifestyle interventions, including nutritious diet, regular exercise, social support, sleep optimization, avoidance of addictive substances, and stress management. Through various means such as training, guidance, and motivation, motivation is formed, goals are determined, and habits are strengthened, ultimately leading to the development of a healthy lifestyle, control of blood pressure indicators, and improvement of quality of life and cognitive function. The intervention period is a total of 3 weeks, on line.

Interventions

BEHAVIORALLifestyle medicine

Lifestyle medicine includes Nutrition , Physical Activity , Stress Management, Restorative Sleep , Social Connectedness, Avoidance of Risky Substances .

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

60 Years to 75 Years

Healthy volunteers

Inclusion criteria

1. Patients whose blood pressure measurements taken at community hospitals meet the hypertension criteria outlined in the Chinese Guidelines for the Prevention and Treatment of Hypertension (2024 revision); 2. Aged 60-75 years old; 3. Have certain abilities in reading, comprehension, and communication; 4. Able to use a smartphone; 5. In the pre-conscious/conscious/preparatory stage. 6. Volunteer to participate in this study and sign the informed consent form.

Exclusion criteria

1. Exclude those with a history of severe heart, brain, kidney diseases or cancer; 2. Patients who currently have or have previously had mental disorders; 3. Patients who are currently participating in other research projects.

Design outcomes

Primary

Measure	Time frame
blood pressure	Baseline, the end of treatment at 3 weeks, and after 3 months
Patient quality of life (SF-36)	Baseline, the end of treatment at 3 weeks, and after 3 months

Secondary

Measure	Time frame
Patient cognitive function (AD8)	Baseline, the end of treatment at 3 weeks, and after 3 months
Patients' lifestyle (HPLP Ⅱ)	Baseline, the end of treatment at 3 weeks, and after 3 months

Contacts

CONTACTLu Zhang

zhangluuz@163.com+8618750236498

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 26, 2026